GlassScriptPhysician profile
Jason A Park
NPI 1184608481
$18,747.97
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,181 · 2020: $300 · 2021: $10K · 2022: $518 · 2023: $3,497 · 2024: $3,022.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,803 · Education: $2,000 · Food and Beverage: $1,716.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,803.08 |
| Education | $2,000.00 |
| Food and Beverage | $1,715.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $10,751.81 | 2019-2023 | Da Vinci Surgical System |
| Tela Bio, INC. | $4,017.97 | 2019-2024 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Becton, Dickinson and Company | $1,653.51 | 2023-2024 | Phasix Mesh, Arista Ah Flexitip |
| Acell, INC. | $988.96 | 2019-2020 | |
| Davol INC. | $804.93 | 2021-2024 | Phasix Mesh |
| Conmed Corporation | $123.40 | 2022-2024 | Airseal |
| Organogenesis INC. | $122.47 | 2022 | |
| Janssen Pharmaceuticals, INC | $68.20 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $46.58 | 2024 | Entyvio |
| Stryker Corporation | $32.81 | 2019 | |
| Allergan, INC. | $24.78 | 2022 | |
| Merck Sharp & Dohme LLC | $22.82 | 2023 | Keytruda |
| Abbvie INC. | $22.30 | 2020 | |
| Convatec INC. | $20.70 | 2024 | |
| Lsi Solutions INC | $19.28 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Focal Therapeutics, INC. | $13.82 | 2020 | |
| Integra Lifesciences Corporation | $13.63 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Park listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.